Use of a Novel Artificial Intelligence Assisted Platform to Assess Optimal Dosing and Treatment Strategy of Erythropoiesis-stimulating Agents (ESA) in Hemodialysis Patients
Clinical trial NCT05032651 · UNKNOWN
Trial details
- NCT number
- NCT05032651
- Sponsor
- Kaohsiung Medical University Chung-Ho Memorial Hospital
- Status
- UNKNOWN
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2021-03-19
- Primary completion
- 2023-12-23
- Enrollment
- 130
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.